AzTrials
AzTrials

Autism Spectrum DisorderNCT06645587

Targeting Repetitive Behaviors in Autism Spectrum Disorder Via Transcranial Direct Current Stimulation

A study testing Active HD-tDCS over pre-SMA and Active HD-tDCS over left DLPFC in people with Autism Spectrum Disorder, run by Bambino Gesù Hospital and Research Institute at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Repetitive behaviors (RBs) are a prevalent feature of Autism Spectrum Disorder (ASD). There are two groups of RBs: lower-order (e.g. motor stereotypies) and higher-order RBs (e.g. restricted interests), linked to sensory-motor and the associative loops, respectively. Read more about this study

Who is it for?
Ages 8 to 13 years
Conditions the study is for
Autism Spectrum Disorder
What is being tested?
Active HD-tDCS over pre-SMA and Active HD-tDCS over left DLPFC
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
78 participants
Where
1 siteItaly
Study dates
3 Oct 2024to Apr 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 13 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • participants of both genders with ASD diagnosis according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and based on clinical evaluation and administration of gold standard tools for ASD diagnosis
  • an intelligence quotient (IQ) higher or equal to 70 (IQ ≥ 70)
  • age range from 8 years to 13 years and 11 months included

Who cannot join

  • the presence of neurological/medical/genetic conditions (i.e., brain tumours or genetic syndromes)
  • personal or family history of epilepsy
  • other primary psychiatric diagnoses (i.e., bipolar disorders, schizophrenia spectrum disorders, or adjustment disorder)
  • sensorimotor deficits
  • the presence of peacemaker or other metal devices in the body;
  • ongoing CNS-active drug treatment
  • receiving other cognitive-behavioral therapies specifically focused on RBs in the 3 months before the study

Trial locations and contacts

1 site in 1 country.

Italy1 site, 1 recruiting
  • Bambino Gesù Children Hospital

    Rome, Italy, 00152

    Chiara Mennini, +390668592572, chiara.mennini@opbg.net

    Recruiting

Other trials in Italy

About this study

Official title: Understanding and Targeting Repetitive Behaviors and Restricted Interests in Autism Spectrum Disorder Via High-Definition Transcranial Direct Current Stimulation

Repetitive behaviors (RBs) are a prevalent feature of Autism Spectrum Disorder (ASD). There are two groups of RBs: lower-order (e.g. motor stereotypies) and higher-order RBs (e.g. restricted interests), linked to sensory-motor and the associative loops, respectively. To date, treatment options for RBs are very limited. High-definition transcranial direct current stimulation (HD-tDCS) may be effective in reducing the impact of RBs in children with ASD by targeting the associated brain alterations. Moreover, the high focality of HD-tDCS will help the investigators to disentangle the relative contribution of different brain loops (namely, sensory-motor and the associative loops) into RBs subtypes. The investigators will also study the electrophysiological patterns associated to behavioral changes after the application of HD-tDCS.

Read the detailed description

The experimental design will be the following: randomized, three-arm, between subject, double blind, and placebo-controlled.

Children and adolescents with ASD will be selected and randomly assigned to three groups: 1. Active high-definition tDCS (HD-tDCS) over pre-SMA; 2. Active high-definition tDCS (HD-tDCS) left DLPFC; 3. Sham high-definition tDCS (HD-tDCS).

In this project, the investigators will work to understand whether a brain-based intervention, with the use of HD-tDCS can enhance RBs in individuals with ASD.

The protocol will allow the investigators to:

  1. Test if Active high-definition tDCS (HD-tDCS) compared to sham HD-tDCS will contribute in reducing RBs
  2. Test if HD-tDCS over pre-SMA cortex will decrease lower-order RBs, while HD-tDCS over dlPFC will decrease higher-order RBs
  3. Test if the Active Groups will significantly improve in the remaining psychological measures compared to the Sham Group
  4. Test if the Active Groups will change in the RBS-R total score will be significantly correlated with changes in neuropsychological and electroencephalographic (EEG) connectivity measures
  5. Test if the Active Groups will change in the RBS-R total score will be significantly correlated with changes in the remaining psychological measures and parental stress.

The overarching goal is to provide a scientific foundation for devising new rehabilitation strategies in ASD.

Being tested
Active HD-tDCS over pre-SMA, Active HD-tDCS over left DLPFC, Sham HD-tDCS
Keywords
Autism Spectrum Disorder, HD-tDCS, Restricted Interests, Repetitive Behaviors, Neurodevelopmental Disorders, transcranial direct current stimulation
Medical subject headings
Autism Spectrum Disorder, Neurodevelopmental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Active HD-tDCS over pre-SMADevice

    Active cathodal HD-tDCS over pre-SMA cortex will be delivered for 10 days (3 sessions per week). The 4 × 1 montage using small circular electrodes (diameter 1 cm) will be applied with the cathode placed centrally over Fz. The current intensity will be set at 0.5 mA for a total of 20 minutes (30 s ramp up/down).

  • Active HD-tDCS over left DLPFCDevice

    Active cathodal HD-tDCS over left DLPFC cortex will be delivered for 10 days (3 sessions per week). The 4 × 1 montage using small circular electrodes (diameter 1 cm) will be applied with the cathode placed centrally over F3. The current intensity will be set at 0.5 mA for a total of 20 minutes (30 s ramp up/down).

  • Sham HD-tDCSDevice

    Sham HD-tDCS will be delivered over pre-SMA or left-dlPFC cortex for 10 days (3 sessions per week). The same electrodes placement as well as the stimulation set-up will be used as in the active stimulation conditions, but the current will be applied for 30 s and will be ramped down (0 mA) during the rest of the session without the participants awareness. Each Sham session will last 20 minutes.

Study groups in NCT06645587
Study groupRoleWhat they receive
Arm Pre-SMAActive comparatorActive cathodal HD-tDCS over pre-SMA cortex. For HD-tDCS a 4 × 1 montage, small circular electrodes (diameter 1 cm) will be used with the cathode placed centrally over Fz with a current intensity of 0.5 mA for a total of 20 minutes (30 s ramp up/down). For the electrodes' placement, the investigators will follow the recommended guidelines for children.
Receives: Device: Active HD-tDCS over pre-SMA
Arm left-dlPFCActive comparatorActive cathodal HD-tDCS over left dlPFC cortex. For HD-tDCS a 4 × 1 montage, small circular electrodes (diameter 1 cm) will be used with the cathode placed centrally over F3 with a current intensity of 0.5 mA for a total of 20 minutes (30 s ramp up/down). For the electrodes' placement, the investigators will follow the recommended guidelines for children.
Receives: Device: Active HD-tDCS over left DLPFC
Arm ShamSham comparatorSham HD-tDCS will be delivered over pre-SMA or left-dlPFC cortex. The same electrodes placement as well as the stimulation set-up will be used as in the active stimulation conditions, but the current will be applied for 30 s and will be ramped down (0 mA) during the rest of the session without the participants awareness.
Receives: Device: Sham HD-tDCS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Repetitive Behavior Scale-Revised

    The primary outcome measure will be the Total Score of the Repetitive Behavior Scale-Revised (Bodfish, 2000). It consists of a 43-item parent-report questionnaire evaluating the extent of RBs in individuals with ASD. The tool encompasses six scales: Stereotyped Behavior (6 items), Self-injurious Behavior (8 items), Compulsive Behavior (8 items), Routine Behavior (6 items), Sameness Behavior (11 items), and Restricted Behavior (4 items). The items are rated on a four-point scale (0-Behavior does not occur, 1-Behavior occurs and is a mild problem, 2-Behavior occurs and is a moderate problem, 3-Behavior occurs and is a severe problem); an overall total raw score and a total number of items score for each subscale are computed. Higher scores indicate greater severity of repetitive behaviors. The sum of all items provides a total raw score ranging from 0 to 129, with higher scores indicating more severe repetitive behaviors.

    Measured: Baseline, pre-intervention; immediately after the intervention; three-month follow-up.

Secondary outcomes (9)
  1. Wisconsin Card Sorting Test

    The version of the Wisconsin Card Sorting Test for developmental stages evaluates executive functions. The Modified Card Sorting Test (MCST; Nelson, 1976) assesses executive functions in children aged 4-13 years. It requires assigning 48 cards, on which one to four symbols are printed in different colors and shapes. The sorting rule (number, shape, color) changes after six correct assignments. The participant must deduce the current rule from the own pattern of responses. The number of right and wrong assignments and the number of errors will be computed.

    Measured: Baseline, pre-intervention; immediately after the intervention; three-month follow-up.

  2. Stop Signal Task

    The Stop Signal Task is a computerized task evaluating inhibitory control. The task is structured in line with the consensus guide of SST (Verbruggen et al., 2019) and it will be performed on PsychoPy® software (Open Science Tools Ltd., Nottingham, UK). The task duration will be approximately 14 minutes. The Stop Signal Task will yield the following measures: stop signal reaction time, calculated in milliseconds by subtracting a mean Stop Signal Delays from the observed mean reaction times in no-stop trials; go accuracy; go reaction times; Stop Signal Delay.

    Measured: Baseline, pre-intervention; immediately after the intervention; three-month follow-up.

  3. Short Sensory Profile 2

    The Short Sensory Profile 2 (Dunn, 2014) is a parent report questionnaire for evaluating the sensory processing pattern in children aged 3-14 years. It contains 34 items. Scores are assigned on a five-point Likert scale and range from "always = 0" to "often = 1" to "sometimes = 2" to "rarely = 3" to "never = 4". Low scores are indicative of frequent dysfunctional behavior. Based on a bell curve normed distribution, the raw score total for each quadrant can be classified as "much less than others" (lower 2%), "less than others" (between 1 SD and 2 SD below the mean, accounting for 14% of the normative sample), "just like the majority of others" (± 1 SD from the mean and accounting for 68% of the normative sample), "more than others" (between 1 SD and 2 SD above the mean), and "much more than others" (upper 2%).

    Measured: Baseline, pre-intervention; immediately after the intervention; three-month follow-up.

  4. Behavior Rating Inventory of Executive Function - Second Edition/ parent report

    The Behavior Rating Inventory of Executive Function (Gioia et al., 2015) is a parent report questionnaire consisting of 63 items for an ecological and comprehensive evaluation of executive functions in children aged 5-18 years. The tool encompasses 63 items evaluating inhibition, self-monitoring, shift, initiation, working memory, emotional control, planning, task-monitoring, and organization of materials. Items are further dived into 4 indices as follows: the Behavior Regulation Index, the Emotion Regulation Index, the Cognitive Regulation Index, and the Global Executive Composite. Raw scores of each scale and index are converted into T scores (M = 50, SD = 10) and percentiles. For all clinical scales and indices, T scores from 60 to 64 and from 65 to 69 are considered respectively mildly elevated and potentially clinically elevated while T scores at or above 70 are clinically significant.

    Measured: Baseline, pre-intervention; immediately after the intervention; three-month follow-up.

  5. Sleep Disturbance Scale for Children

    The Sleep Disturbance Scale for Children (Bruni et al., 1996) is a parent report questionnaire for evaluating the sleep functioning of children and adolescents aged 6-16 years. The tool investigates the occurrence of sleep disturbances in the previous six months throughout 26 items on a five-point Likert scale (1 = least severe and 5 = most severe). It encompasses the following scales: difficulty in initiating and maintaining sleep, sleep-disordered breathing, disorders of arousal, sleep-wake disorders, disorders of excessive somnolence, and sleep hyperhidrosis. The sum of all items provides a total raw score ranging from 26 to 130, with higher scores indicating more sleep difficulties. A T score of >70 is clinically significant while T scores under 60 or ranged 61-69 are respectively in the average or borderline range.

    Measured: Baseline, pre-intervention; immediately after the intervention; three-month follow-up.

  6. Child Behaviour Checklis/ 6-18

    The Child Behaviour Checklist/ 6-18 (Achenbach and Rescorla, 2001) is a parent report questionnaire to evaluate behavioral and psychopathological symptoms during the preceding 6 months in individuals aged 6-18 years. It includes 113 items on a three-point Likert scale (0 = not true; 1 = somewhat or sometimes true; 2 = very true or often true). According to the cut-off thresholds of Achenbach and Rescorla (2001), T-scores > 69 were classified as clinically relevant, t-scores between 65 and 69 were classified as borderline, and T-scores < 65 indicated non-clinical symptoms. For the internalizing problems, externalizing problems, and total problems scales, T-scores > 63 were classified as clinically relevant, T-scores between 60 and 63 were classified as borderline, and T-scores < 60 indicated non-clinical symptoms.

    Measured: Baseline, pre-intervention; immediately after the intervention; three-month follow-up.

  7. Childhood Autism Rating Scale-2

    The Childhood Autism Rating Scale-2 (Schopler et al., 2010) is a rating scale for symptoms related to ASD. Higher scores indicate more severe symptoms of ASD. The instrument is designed for children aged 2-6 years or in individuals with ASD and low functioning (IQ ≤ 79 and regardless the child's age - Standard Form), and individuals with ASD and high functioning (IQ>80 - High Functioning Form). Both versions contain 15 items rated on a 4-point scale with higher scores revealing more severe symptoms related to ASD. The total raw score is converted into standard score within three ASD severity levels: no or minimum symptoms of ASD (15-29.5 or 15-27.5 with >13 years for the standard form; 15-27.5 for the high functioning form) mild to moderate symptoms of ASD (30-30.6 or 28-34.5 with >13 years for the standard form; 28-33.5 for the high functioning form), and moderate to severe symptoms of ASD (>35 or >37 with >13 years for the standard form; >34 for the high functioning form).

    Measured: Baseline, pre-intervention; immediately after the intervention; three-month follow-up.

  8. Parenting Stress Index Short Form

    The Parenting Stress Index Short Form (Abidin, 1997) is a self-report questionnaire designed to evaluate parental stress levels in parents of children aged 1 month to 12 years. The instrument is used in both clinical and research settings. It contains 36 items rated on a five-point Likert scale (1 = strongly disagree and 5 = strongly agree). Items encompass three subscales as follows, parental distress or the experienced distress in the role of being a parent, difficult child linked to the child's behavioral problems, and parent-child dysfunctional interaction. The sum of all items results in the Total Stress score. The total raw score is converted into percentile score; percentile ≥85 is considered as clinically significant.

    Measured: Baseline, pre-intervention; immediately after the intervention; three-month follow-up.

  9. Electroencephalography (HD-EEG)

    Resting-state EEGs will be recorded in a sound-attenuated, electrically shielded room to minimize external noise and interference.

    Measured: Baseline, pre-intervention and immediately after the intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Oct 2024
  2. Study start3 Oct 2024
  3. Primary completionJan 2026 (estimated)
  4. Study completionApr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
78 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06645587
Sponsor's protocol ID
GR-2021-12375413
Status last verified
Sep 2024
First submitted
11 Oct 2024
Last updated
17 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Lazzaro G, Passarini S, Battisti A, Costanzo F, Garone G, Mercier M, D'Aiello B, De Rossi P, Valeri G, Guerrera S, Casula L, Menghini D, Vicari S, Fuca E. Understanding and targeting repetitive behaviors and restricted interests in autism spectrum disorder via high-definition transcranial direct current stimulation: a study-protocol. BMC Psychiatry. 2025 Feb 25;25(1):170. doi: 10.1186/s12888-025-06506-y.

    PubMed 40001028

Questions about this trial

What is this clinical trial studying?

A study testing Active HD-tDCS over pre-SMA and Active HD-tDCS over left DLPFC in people with Autism Spectrum Disorder, run by Bambino Gesù Hospital and Research Institute at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Repetitive Behavior Scale-Revised (time frame: Baseline, pre-intervention; immediately after the intervention; three-month follow-up.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06645587, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in